Dr. Bosch on the HPV Vaccination in the Prevention of Cervical Cancer

Xavier Bosch, MD, MPH
Published: Wednesday, Nov 08, 2017



Xavier Bosch, MD, MPH, Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Catala d' Oncologia–Catalan Institute of Oncology, introduces a second-generation vaccination against the human papilloma virus (HPV) for the prevention of cervical cancer.

A second-generation HPV vaccine has arrived in Europe, states Bosch. This vaccine protects against 7 of the HPV types that cause cervical cancer, as well as other HPV-related malignancies in males and females.
 


Xavier Bosch, MD, MPH, Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Catala d' Oncologia–Catalan Institute of Oncology, introduces a second-generation vaccination against the human papilloma virus (HPV) for the prevention of cervical cancer.

A second-generation HPV vaccine has arrived in Europe, states Bosch. This vaccine protects against 7 of the HPV types that cause cervical cancer, as well as other HPV-related malignancies in males and females.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Rapid Reviews in Oncology®: Practice-Changing Data in Acute Myeloid Leukemia: A Rapid Update From Atlanta OnlineDec 21, 20182.0
Community Practice Connections™: 2nd Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesDec 30, 20182.0
Publication Bottom Border
Border Publication
x